文献速递慢病管理预防保健、筛查与疫苗

成人难治性高血压:评估与治疗

Resistant Hypertension in Adults: Evaluation and Treatment.
PubMed 文献 · Am Fam Physician · 2026-01-01

难治性高血压定义为使用包括利尿剂在内的三种降压药达最大或最佳剂量后血压仍高于目标值。家庭医生在诊断前应评估合并症、用药依从性、白大衣高血压、继发性高血压及治疗不足,并确保诊室血压测量准确及家庭血压监测确认。管理包括循证生活方式干预、社会因素调整及个体化用药,初始三联方案应包含二氢吡啶类钙通道阻滞剂、血管紧张素受体拮抗剂或血管紧张素转换酶抑制剂及噻嗪类利尿剂。

要点

  • 诊断难治性高血压前需排除假性难治,包括白大衣高血压、用药不依从、继发性高血压等。
  • 初始三联方案应包含二氢吡啶类CCB、ARB或ACEI及噻嗪类利尿剂。
  • 盐皮质激素受体拮抗剂是首选的第四线药物。

核心结论

  • 难治性高血压的管理需综合评估、生活方式干预、个体化用药及必要时介入治疗。

研究设计与样本

  • 本文为综述,检索范围未在摘要中报告。

主要发现

  • 难治性高血压定义为使用包括利尿剂在内的三种降压药达最大或最佳剂量后血压仍高于目标值。
  • 治疗可能不充分的原因包括未使用优选降压药、药物剂量不足、未处理生活方式因素、合并症治疗不当或未识别社会因素。

关键数值与推荐

  • 初始三联方案应包含二氢吡啶类钙通道阻滞剂、血管紧张素受体拮抗剂或血管紧张素转换酶抑制剂及噻嗪类利尿剂。
  • 盐皮质激素受体拮抗剂是难治性高血压首选的第四线药物。
  • 对于无法耐受药物或血压控制不佳的患者,应考虑转诊评估介入选项(如肾交感神经消融术、颈动脉压力感受器放大术)。

临床怎么用

  • 家庭医生应评估难以控制血压患者的合并症、用药依从性、白大衣高血压、继发性高血压及治疗不足。
  • 确保诊室血压测量准确并使用家庭血压监测确认。
  • 管理应包括循证生活方式干预、社会因素调整计划及个体化用药方案。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Difficult-to-control hypertension is a common issue in primary care. Resistant hypertension is defined as a blood pressure (BP) measurement above goal despite the use of maximum or optimal dosages of three antihypertensive agents, including a diuretic. Before diagnosing resistant hypertension, family physicians should evaluate patients with difficult-to-control BP for comorbid conditions, medication nonadherence, white coat hypertension, secondary hyper-tension, and suboptimal therapy. Attention should be focused on ensuring accurate BP measurement technique in the office and confirmatory BP monitoring at home. Management of resistant hypertension should include evidence-based lifestyle interventions, adjustment of plans for social factors, and individualized medication regimens. A dihydropyridine calcium channel blocker, an angiotensin receptor blocker or angiotensin-converting enzyme inhibitor, and a thiazide diuretic should be part of the initial three-drug regimen. Therapy may be suboptimal if preferred antihypertensives are not used, medications are inadequately dosed, lifestyle factors are not addressed, comorbidities are improperly treated, or social factors are not recognized. In patients with resistant hypertension, a mineralocorticoid receptor antagonist is the preferred fourth-line option. Other antihypertensives to improve BP control should be considered based on patient factors and shared decision-making. For patients who are unable to tolerate medications or achieve adequate BP control, referral for interventional options (eg, renal sympathetic denervation, carotid baroreceptor amplification) should be considered.

来源:Am Fam Physician,查看原文。版权归原作者所有。

引用

  1. Haley SP, Bragg S, Stem L, et al. Resistant Hypertension in Adults: Evaluation and Treatment. Am Fam Physician. 2026. PMID: 41544280

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。